P19-25. A vaccine model to prevent the depletion of uninfected bystander CD4 cells during HIV infection

by Le Grand R, Fausther-Bovendo H, Vieillard V, Debre P
Published 2009-10-01

P18-08. Characterization of CD34+ derived dendritic cells generated <it>in vitro </it>and transfected with HIV gene as potential therapeutic vaccine in macaque

by Le Grand R, Vanham G, Banchereau J, Van Gulck E, Zurawski G, Romain G, Martinon F
Published 2009-10-01

P17-16. Anti-Langerin-HIV Gag p24 fusion protein targeting Langerhans cells as a new anti-HIV vaccine strategy

by Le Grand R, Banchereau J, Delache B, Brochard P, Zurawsky G, Flamar A, Culina S, Martinon F
Published 2009-10-01

P11-15. Induction of a mucosal immune response to HIV after systemic immunization with poly(lactic acid) nanoparticles formulated with gag antigen and polyI:C

by Delair T, Luciani E, Calamel A, Munier S, Martinon F, Weber C, Primard C, Le Grand R, Verrier B
Published 2009-10-01

P19-26. Directing macaque immune responses with an anti-dendritic cell HIV Gag p24 fusion protein vaccine

by Martinon F, Dereuddre-Bosquet N, Méderlé-Mangeot I, Flamar A, Zurawski S, Verrier B, Oh S, Zurawski G, Banchereau J, Le Grand R
Published 2009-10-01

Non-neutralizing IgG anti-PID antibodies decreased viral load following high dose vaginal challenge of non-human primates

by Moog C, Dereuddre-Bosquet N, Biedma M, Schmidt S, Decoville T, Mangeot I, Zolla-Pazner S, Vcelar B, Katinger D, Holl V, Le Grand R
Published 2012-09-01

OA05-03. Efficacy study of a T-cell-based DNA vaccine delivered by intradermal electrotransfer in macaques

by Le Grand R, Ustav M, Stanescu I, Männik A, Kaldma K, Sikut R, Méderlé-Mangeot I, Baron M, Dereuddre-Bosquet N, Martinon F
Published 2009-10-01

P17-11. HIV DNA vaccine delivery in association with electroporation in the skin of nonhuman primates

by Le Grand R, Ustav M, Stanescu I, Kivisild T, Toots U, Männik A, Sikut R, Adojaan M, Kaldma K, Mannioui A, Culina S, Martinon F
Published 2009-10-01

Mapping of SIVmac T-cell epitopes in cynomolgus macaques immunized with auxo-GTU-MultiSIV DNA by the intradermal route followed by electroporation

by Corneau A, Maciel Da Silva B, Even S, Morin J, Sylla N, Martinon F, Aarninck A, Blancher A, Stanescu I, Le Grand R, Dereuddre-Bosquet N
Published 2012-09-01

P17-10. A new AuxoGTU-HIV B DNA vaccine induce very long lasting HIV specific T cells response which is efficiently boosted with HIV LAI lipopeptides

by Le-Grand R, Lévy Y, Derreudre-Bosquet N, Stanescu I, Ustav M, Sikut R, Kaldma K, Langlois S, Corneau A, Sylla N, Mangeot-Méderlé I, Martinon F
Published 2009-10-01

Loss and regain of SIV control upon CD8+ cell depletion in vivo in SIV-controller macaques is not associated with efficient SIV specific CD8+ T-cells

by Hamimi C, Bruel T, Dereuddre-Bosquet N, Cosma A, Shin S, Corneau A, Versmisse P, Torres C, Delache B, Even S, Guenounou S, Targat B, Malleret B, Karlsson I, Barré-Sinoussi F, Le-Grand R, Pancino G, Saez-Cirion A, Vaslin B
Published 2012-09-01

Liposomal formulation of Gp41 derivate with adjuvant MPLA: vaccine design, immunogenicity in animals and safety in humans

by Katinger D, Wagner A, Luque I, Crespillo S, Conejero-Lara F, Roger M, Martin C, Mouz N, Mourao S, Farsang A, Notka F, Malcolm K, Bosquet N, Le Grand R, Moog C, Cope A, Shattock R, Lewis DJ, El Habib R
Published 2012-09-01